Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

With the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to creating ...

Scientists in China have developed a potential vaccine to prevent the build-up of plaque in arteries that can lead to blood ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

The vaccine, developed by scientists at Nanjing University of Science and Technology, has shown promise in reducing the ...

The cocktail design of vaccine, tried on mice by Chinese scientists, mitigates the progression of fatty plaque in arteries ...

Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of ...

In the current trials, we do a biopsy of the patient, sequence the tissue, send it to the pharmaceutical company, and they design a personalized vaccine that’s bespoke to that patient’s cancer.